GRI standards

nxr_UCB_csr16_icons_circle-full.png Full disclosure

nxr_UCB_csr16_icons_circle-half.png Partial disclosure

βIndication that Standard Disclosure item is externally assured

Universal standards

Organization profile

Disclosure

External assurance

Report reference

102-1

Name of the organization

nxr_UCB_csr16_icons_circle-full.png

 

Letter to our stakeholders

102-2

Activities, brands, products, and services

nxr_UCB_csr16_icons_circle-full.png

 

Letter to our stakeholders

102-3

Location of headquarters

nxr_UCB_csr16_icons_circle-full.png

 

We are UCB

102-4

Location of operations

nxr_UCB_csr16_icons_circle-full.png

β

Letter to our stakeholders

102-5

Ownership and legal form

nxr_UCB_csr16_icons_circle-full.png

 

Corporate governance statement

102-6

Markets served

nxr_UCB_csr16_icons_circle-full.png

β

We are UCB

102-7

Scale of the organization

nxr_UCB_csr16_icons_circle-full.png

β

Letter to our stakeholders
People data

 

Total number of employees

nxr_UCB_csr16_icons_circle-full.png

β

People data

 

Total number of operations

nxr_UCB_csr16_icons_circle-full.png

β

Letter to our stakeholders

 

Net sales (for private sector organizations) or net revenues (for public sector organizations)

nxr_UCB_csr16_icons_circle-full.png

β

Letter to our stakeholders

 

Total capitalization (for private sector organizations) broken down in terms of debt and equity

nxr_UCB_csr16_icons_circle-full.png

β

Letter to our stakeholders

 

Quantity of products or services provided

nxr_UCB_csr16_icons_circle-full.png

 

Letter to our stakeholders

102-8

Information on employees and other workers

nxr_UCB_csr16_icons_circle-full.png

β

Our people

 

Total number of employees by employment contract (permanent and temporary), by gender

nxr_UCB_csr16_icons_circle-full.png

β

Our people
People data

 

Total number of employees by employment contract (permanent and temporary), by region

nxr_UCB_csr16_icons_circle-full.png

β

Our people
People data

 

Total number of employees by employment type (full-time and part-time), by gender

nxr_UCB_csr16_icons_circle-full.png

β

Our people
People data

 

Whether a significant portion of the organization’s activities are performed by workers who are not employees. If applicable, a description of the nature and scale of work performed by workers who are not employees

nxr_UCB_csr16_icons_circle-full.png

β

Our people
People data

 

Any significant variations in the numbers reported in Disclosures 102-8-a, 102-8-b, and 102-8-c (such as seasonal variations in the tourism or agricultural industries)

nxr_UCB_csr16_icons_circle-full.png

 

Our people
People data

 

An explanation of how the data have been compiled, including any assumptions made

nxr_UCB_csr16_icons_circle-full.png

β

Our people
People data

102-9

Supply chain

nxr_UCB_csr16_icons_circle-full.png

 

Supply chain and procurement

102-10

Significant changes to the organization and its supply chain

nxr_UCB_csr16_icons_circle-full.png

 

No significant changes in the organization and its supply chain

102-11

Precautionary Principle or approach

nxr_UCB_csr16_icons_circle-full.png

 

Our environmental footprint

102-12

External initiatives

nxr_UCB_csr16_icons_circle-full.png

 

Relations with industry associations
Access to Health in CSR projects

102-13

Membership of associations

nxr_UCB_csr16_icons_circle-full.png

 

Relations with industry associations
Access to Health in CSR projects

 

 

 

 

 

Strategy

Disclosure

External assurance

Report reference

102-14

Statement from senior decision-maker

nxr_UCB_csr16_icons_circle-full.png

 

Letter to our stakeholders

102-15

Key impacts, risks, and opportunities

nxr_UCB_csr16_icons_circle-full.png

 

Risk management
Stakeholder engagement and materiality

 

 

 

 

 

Ethics and integrity

Disclosure

External assurance

Report reference

102-16

Values, principles, standards, and norms of behavior

nxr_UCB_csr16_icons_circle-full.png

β

We are UCB

102-17

Mechanisms for advice and concerns about ethics

nxr_UCB_csr16_icons_circle-full.png

 

Code of Conduct
Procurement
Human rights

 

 

 

 

 

Governance

Disclosure

External assurance

Report reference

102-18

Governance structure

nxr_UCB_csr16_icons_circle-full.png

β

Our governance

102-20

Executive-level responsibility for economic, environmental, and social topics

nxr_UCB_csr16_icons_circle-full.png

 

Corporate Societal Responsibility Board

102-21

Consulting stakeholders on economic, environmental, and social topics

nxr_UCB_csr16_icons_circle-full.png

 

Stakeholder engagement and materiality

102-22

Composition of the highest governance body and its committees

nxr_UCB_csr16_icons_circle-full.png

 

Board of Directors and Board committees

102-23

Chair of the highest governance body

nxr_UCB_csr16_icons_circle-full.png

 

Board of Directors and Board committees

102-24

Nominating and selecting the highest governance body

nxr_UCB_csr16_icons_circle-half.png

 

Governance, Nomination and Compensation Committee

102-26

Role of highest governance body in setting purpose, values, and strategy

nxr_UCB_csr16_icons_circle-half.png

 

Executive Committee

102-30

Effectiveness of risk management processes

nxr_UCB_csr16_icons_circle-full.png

 

Risk management

102-32

Highest governance body’s role in sustainability reporting

nxr_UCB_csr16_icons_circle-full.png

 

Corporate Societal Responsibility Board

102-40

List of stakeholder groups

nxr_UCB_csr16_icons_circle-full.png

 

Stakeholder engagement and materiality

102-41

Collective bargaining agreements

nxr_UCB_csr16_icons_circle-half.png

 

Collective bargaining agreements are country-specific

 

 

 

 

 

Stakeholder engagement

Disclosure

External assurance

Report reference

102-42

Identifying and selecting stakeholders

nxr_UCB_csr16_icons_circle-full.png

 

Stakeholder engagement and materiality

102-43

Approach to stakeholder engagement

nxr_UCB_csr16_icons_circle-full.png

 

Stakeholder engagement and materiality

102-44

Key topics and concerns raised

nxr_UCB_csr16_icons_circle-full.png

 

Stakeholder engagement and materiality

 

 

 

 

 

Reporting principles

Disclosure

External assurance

Report reference

102-45

Entities included in the consolidated financial statements

nxr_UCB_csr16_icons_circle-full.png

 

Our financials

102-46

Defining report content and topic Boundaries

nxr_UCB_csr16_icons_circle-full.png

 

Stakeholder engagement and materiality

102-47

List of material topics

nxr_UCB_csr16_icons_circle-full.png

 

Stakeholder engagement and materiality

102-48

Restatements of information

nxr_UCB_csr16_icons_circle-full.png

 

Our environmental footprint

102-49

Changes in reporting

nxr_UCB_csr16_icons_circle-full.png

 

Stakeholder engagement and materiality (Scope)

102-50

Reporting period

nxr_UCB_csr16_icons_circle-full.png

β

Stakeholder engagement and materiality (Scope)

102-51

Date of most recent report

nxr_UCB_csr16_icons_circle-full.png

β

Stakeholder engagement and materiality (Scope)

102-52

Reporting cycle

nxr_UCB_csr16_icons_circle-full.png

β

Stakeholder engagement and materiality (Scope)

102-53

Contact point for questions regarding the report

nxr_UCB_csr16_icons_circle-full.png

β

Contact details

102-54

Claims of reporting in accordance with the GRI Standards

nxr_UCB_csr16_icons_circle-full.png

β

Stakeholder engagement and materiality

102-55

GRI content index

nxr_UCB_csr16_icons_circle-full.png

β

GRI tables

102-56

External assurance

nxr_UCB_csr16_icons_circle-full.png

β

Assurance report

 

 

 

 

 

Topic specific standards

Economic

Economic performance

Disclosure

External assurance

Report reference

GRI 201: Economic performance 2018

 

 

 

201-1

Direct economic value generated and distributed

nxr_UCB_csr16_icons_circle-full.png

β

Our financials

201-3

Defined benefit plan obligations and other retirement plans

nxr_UCB_csr16_icons_circle-full.png

β

Our financials
Employee benefits

 

 

 

 

 

Market presence

Disclosure

External assurance

Report reference

GRI 202: Market presence 2018

 

 

 

202-2

Proportion of senior management hired from the local community

nxr_UCB_csr16_icons_circle-full.png

 

Diversity and inclusion

 

 

 

 

 

Anti-corruption

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspect ‘Personal and Confidential Information, Business Ethics and Anti-Bribery and Anti-Corruption’ are being managed by the Ethics and Compliance department, within the Legal Patient Value Function.

GRI 205: Anti-corruption 2018

 

 

 

205-1

Operations assessed for risks related to corruption

nxr_UCB_csr16_icons_circle-half.png

 

Anti-bribery and anti-corruption

205-2

Communication and training about anti-corruption policies and procedures

nxr_UCB_csr16_icons_circle-half.png

 

Code of Conduct
Compliance Monitoring

 

Total number and percentage of governance body members that the organization’s anti-corruption policies and procedures have been communicated to, broken down by region

 

 

No disclosure

 

Total number and percentage of employees that the organization’s anti-corruption policies and procedures have been communicated to, broken down by employee category and region

 

 

No disclosure

 

Total number and percentage of business partners that the organization’s anti-corruption policies and procedures have been communicated to, broken down by type of business partner and region. Describe if the organization’s anti-corruption policies and procedures have been communicated to any other persons or organizations

 

 

No disclosure

 

Total number and percentage of governance body members that have received training on anti-corruption, broken down by region

 

 

No disclosure

 

Total number and percentage of employees that have received training on anti-corruption, broken down by employee category and region

nxr_UCB_csr16_icons_circle-half.png

β

Code of Conduct

205-3

Confirmed incidents of corruption and actions taken

nxr_UCB_csr16_icons_circle-half.png

 

Anti-bribery and anti-corruption

 

 

 

 

 

Environmental

Energy

Disclosure

External assurance

Report reference

GRI 302: Energy 2018

 

 

 

302-1

Energy consumption within the organization

nxr_UCB_csr16_icons_circle-full.png

β

Towards carbon neutrality

302-4

Reduction of energy consumption

nxr_UCB_csr16_icons_circle-full.png

 

Towards carbon neutrality

 

 

 

 

 

Water

Disclosure

External assurance

Report reference

GRI 303: Water and effluents 2018

 

 

 

303-1

Water withdrawal by source

nxr_UCB_csr16_icons_circle-full.png

β

Water withdrawal

 

 

 

 

 

Emissions

Disclosure

External assurance

Report reference

GRI 305: Emissions 2018

 

 

 

305-1

Direct (Scope 1) GHG emissions

nxr_UCB_csr16_icons_circle-full.png

β

Carbon reduction

305-2

Energy indirect (Scope 2) GHG emissions

nxr_UCB_csr16_icons_circle-full.png

β

Carbon reduction

305-3

Other indirect (Scope 3) GHG emissions

nxr_UCB_csr16_icons_circle-half.png

 

Carbon reduction

 

 

 

 

 

Effluents and waste

Disclosure

External assurance

Report reference

GRI 306: Effluents and waste 2018

 

 

 

306-2

Waste by type and disposal method

nxr_UCB_csr16_icons_circle-full.png

β

Waste production

306-3

Significant spills

nxr_UCB_csr16_icons_circle-full.png

β

Waste production

306-4

Transport of hazardous waste

nxr_UCB_csr16_icons_circle-full.png

β

Waste production

 

 

 

 

 

Social

Employment

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘People Management and People Development’ are being managed by the Talent and Company Reputation Patient Value Function.

GRI 401: Employment 2018

 

 

 

401-1

New employee hires and employee turnover

nxr_UCB_csr16_icons_circle-full.png

β

People attraction and recruitment
People departures

 

 

 

 

 

Occupational health and safety

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘People Management and People Development’ are being managed by the Talent and Company Reputation Patient Value Function.

GRI 403: Occupational health and safety 2018

 

 

 

403-2

Types of injury and rates of injury, occupational diseases, lost days, and absenteeism, and number of work-related fatalities

nxr_UCB_csr16_icons_circle-half.png

 

People well-being and occupational health and safety

403-3

Workers with high incidence or high risk of diseases related to their occupation

nxr_UCB_csr16_icons_circle-half.png

 

People well-being and occupational health and safety

 

 

 

 

 

Training and education

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘People Management and People Development’ are being managed by the Talent and Company Reputation Patient Value Function.

GRI 404: Training and education 2018

 

 

 

404-1

Average hours of training per year per employee

nxr_UCB_csr16_icons_circle-full.png

β

Learning at UCB

404-3

Percentage of employees receiving regular performance and career development reviews

nxr_UCB_csr16_icons_circle-half.png

 

Performance review of our people

 

 

 

 

 

Diversity and equal opportunity

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘People Management and People Development’ are being managed by the Talent and Company Reputation Patient Value Function.

GRI 405: Diversity and equal opportunity 2018

 

 

 

405-1

Diversity of governance bodies and employees

nxr_UCB_csr16_icons_circle-full.png

β

Diversity at Board and Executive Committee level
People data

 

 

 

 

 

Non-discrimination

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspect ‘Personal and Confidential Information, Business Ethics and Anti-Bribery and Anti-Corruption’ are being managed by the Ethics and Compliance department, within the Legal Patient Value Function.

GRI 406: Non-discrimination 2018

 

 

 

406-1

Incidents of discrimination and corrective actions taken

nxr_UCB_csr16_icons_circle-full.png

 

Our people

 

 

 

 

 

Child labor

Disclosure

External assurance

Report reference

GRI 408: Child labor 2018

 

 

 

408-1

Operations and suppliers at significant risk for incidents of child labor

nxr_UCB_csr16_icons_circle-half.png

 

Code of Conduct

 

 

 

 

 

Human rights assessment

Disclosure

External assurance

Report reference

GRI 412: Human rights assessment 2018

 

 

 

412-2

Employee training on human rights policies or procedures

nxr_UCB_csr16_icons_circle-half.png

 

Code of Conduct

 

Total number of hours in the reporting period devoted to training on human rights policies or procedures concerning aspects of human rights that are relevant to operations

 

 

No disclosure

 

Percentage of employees trained during the reporting period in human rights policies or procedures concerning aspects of human rights that are relevant to operations

nxr_UCB_csr16_icons_circle-full.png

β

Code of Conduct

 

 

 

 

 

Local communities

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘Access to Health and Medicines, Pricing and Disease Awareness and Education’ are being managed by the Marketing and Patient Access Patient Value Practice and Talent and Company Reputation Patient Value Function, supported by other departments.

GRI 413: Local communities 2018

 

 

 

413-1

Operations with local community engagement, impact assessments, and development programs

nxr_UCB_csr16_icons_circle-full.png

 

Our people
Our community engagement
Access to Health in CSR projects

 

 

 

 

 

Public policy

Disclosure

External assurance

Report reference

GRI 415: Public policy 2018

 

 

 

415-1

Political contributions

nxr_UCB_csr16_icons_circle-half.png

 

Relations with public authorities

 

 

 

 

 

Customer health and safety

Disclosure

External assurance

Report reference

GRI 416: Customer health and safety 2018

 

 

 

416-1

Assessment of the health and safety impacts of product and service categories

nxr_UCB_csr16_icons_circle-full.png

 

Patient and drug safety

416-2

Incidents of non-compliance concerning the health and safety impacts of products and services

nxr_UCB_csr16_icons_circle-full.png

 

Patient and drug safety

 

 

 

 

 

Marketing and labeling

Disclosure

External assurance

Report reference

GRI 417: Marketing and labeling 2018

 

 

 

417-1

Requirements for product and service information and labeling

nxr_UCB_csr16_icons_circle-full.png

 

Product responsibility

417-3

Incidents of non-compliance concerning marketing communications

nxr_UCB_csr16_icons_circle-half.png

 

Marketing communications and unsolicited medical information requests

 

 

 

 

 

Customer privacy

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspect ‘Personal and Confidential Information, Business Ethics and Anti-Bribery and Anti-Corruption’ are being managed by the Ethics and Compliance department, within the Legal Patient Value Function.

GRI 418: Customer privacy 2018

 

 

 

418-1

Substantiated complaints concerning breaches of customer privacy and losses of customer data

nxr_UCB_csr16_icons_circle-full.png

 

Risk management

 

 

 

 

 

Socio-economic compliance

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspect ‘Personal and Confidential Information, Business Ethics and Anti-Bribery and Anti-Corruption’ are being managed by the Ethics and Compliance department, within the Legal Patient Value Function.

GRI 419: Socio-economic compliance 2018

 

 

 

419-1

Non-compliance with laws and regulations in the social and economic area

nxr_UCB_csr16_icons_circle-full.png

 

Relations with public authorities

 

 

 

 

 

Employee engagement

Disclosure

External assurance

Report reference

GRI 501: Employee engagement 2018

 

 

 

501-1

Percentage of colleagues engaging in Employee survey

nxr_UCB_csr16_icons_circle-full.png

 

People insights

501-2

Percentage of colleagues completing the mandatory training programs

nxr_UCB_csr16_icons_circle-full.png

 

Code of Conduct

501-3

Initiatives in support of environmental sustainability and awareness organized by colleagues

nxr_UCB_csr16_icons_circle-half.png

 

From green strategy to green action

501-4

Initiatives in support of UCB’s CSR patient initiatives in resource-poor countries organized by colleagues

nxr_UCB_csr16_icons_circle-half.png

 

No activity was organized in 2018

 

 

 

 

 

Innovation

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘Innovation, Research and Development’ are being managed by the New Medicines Patient Value Unit and the Corporate Strategy and Business Development Patient Value Function, supported by other departments.

GRI 502: Innovation 2018

 

 

 

502-1

Percentage of the revenue invested in R&D

nxr_UCB_csr16_icons_circle-full.png

 

From Patient Value Strategy to action in R&D
Innovation

 

 

 

 

 

Pricing

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘Access to Health and Medicines, Pricing and Disease Awareness and Education’ are being managed by the Marketing and Patient Access Patient Value Practice and Talent and Company Reputation Patient Value Function, supported by other departments.

GRI 503: Pricing 2018

 

 

 

503-1

Access initiatives

nxr_UCB_csr16_icons_circle-half.png

 

From Patient Value Strategy to patient access
Risk management

 

 

 

 

 

Disease awareness

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘Access to Health and Medicines, Pricing and Disease Awareness and Education’ are being managed by the Marketing and Patient Access Patient Value Practice and Talent and Company Reputation Patient Value Function, supported by other departments.

GRI 504: Disease awareness 2018

 

 

 

504-1

Disease awareness and education

nxr_UCB_csr16_icons_circle-full.png

 

Raising disease awareness

 

 

 

 

 

Access to health

Disclosure

External assurance

Report reference

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘Access to Health and Medicines, Pricing and Disease Awareness and Education’ are being managed by the Marketing and Patient Access Patient Value Practice and Talent and Company Reputation Patient Value Function, supported by other departments.

GRI 505: Access to health 2018

 

 

 

505-1

Access to health in resource-poor countries

nxr_UCB_csr16_icons_circle-full.png

 

Access to health in CSR projects

 

 

 

 

 

nxr_UCB_csr16_icons_circle-full.png Full disclosure

nxr_UCB_csr16_icons_circle-half.png Partial disclosure

βIndication that Standard Disclosure item is externally assured